Cannabinoid type 1 (CB1) receptor antagonist AM 251 reduces food intake and bodyweight without causing conditioned taste aversion

被引：0
|
作者：
Chambers, A
Koopmans, H
Pittman, Q
Sharkey, K
机构：
来源：
OBESITY RESEARCH | 2005年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A44 / A44
页数：1
相关论文
共 50 条
  • [31] Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration
    Rodriguez, Jesse S.
    Boctor, Sherin Y.
    Flores, Luke C.
    Phelix, Clyde F.
    Martinez, Joe L., Jr.
    [J]. NEUROSCIENCE LETTERS, 2011, 489 (03) : 187 - 191
  • [32] Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats
    Cippitelli, A
    Bilbao, A
    Hansson, AC
    del Arco, I
    Sommer, W
    Heilig, M
    Massi, M
    Bermúdez-Silva, FJ
    Navarro, M
    Ciccocioppo, R
    de Fonseca, FR
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (08) : 2243 - 2251
  • [33] Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist
    Botanas, Chrislean Jun
    de la Pena, June Bryan
    de la Pena, Irene Joy
    Tampus, Reinholdgher
    Kim, Hee Jin
    Yoon, Seong Shoon
    Seo, Joung-Wook
    Jeong, Eun Ju
    Cheong, Jae Hoon
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 766 : 135 - 141
  • [34] Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?
    Doggrell, SA
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (12) : 2141 - 2144
  • [35] The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats
    Sink, K. S.
    Segovia, K. N.
    Collins, L. E.
    Markus, E. J.
    Vemuri, V. K.
    Makriyannis, A.
    Salamone, J. D.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 95 (04) : 479 - 484
  • [36] The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat
    Cluny, Nina L.
    Chambers, Adam P.
    Vemuri, V. Kiran
    Wood, JodiAnne T.
    Eller, Lindsay K.
    Freni, Carmelina
    Reimer, Raylene A.
    Makriyannis, Alexandros
    Sharkey, Keith A.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 97 (03) : 537 - 543
  • [37] Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats
    K. S. Sink
    K. N. Segovia
    E. J. Nunes
    L. E. Collins
    V. K. Vemuri
    G. Thakur
    A. Makriyannis
    J. D. Salamone
    [J]. Psychopharmacology, 2009, 206 : 223 - 232
  • [38] Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats
    Sink, K. S.
    Segovia, K. N.
    Nunes, E. J.
    Collins, L. E.
    Vemuri, V. K.
    Thakur, G.
    Makriyannis, A.
    Salamone, J. D.
    [J]. PSYCHOPHARMACOLOGY, 2009, 206 (02) : 223 - 232
  • [39] Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion
    Liberato Costa da Veiga, Marco Aurelio
    Bloise, Flavia Fonseca
    Costa-e-Sousa, Ricardo Henrique
    Souza, Luana Lopes
    dos Santos Almeida, Norma Aparecida
    Oliveira, Karen Jesus
    Pazos-Moura, Carmen Cabanelas
    [J]. JOURNAL OF ENDOCRINOLOGY, 2008, 199 (02) : 235 - 242
  • [40] Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387
    McLaughlin, Peter J.
    Qian, Liu
    Wood, JodiAnne T.
    Wisniecki, Ania
    Winston, Keisha M.
    Swezey, Lynn A.
    Ishiwari, Keita
    Betz, Adrienne J.
    Pandarinathan, Lakshmipathi
    Xu, Wei
    Makriyannis, Alexandros
    Salamone, John D.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 83 (03) : 396 - 402
12345